RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.71B
1-Year Est. Return 43.68%
This Quarter Est. Return
1 Year Est. Return
+43.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.71B
AUM Growth
+$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
101
New
Increased
Reduced
Closed

Top Buys

1 +$11M
2 +$8.41M
3 +$7.09M
4
TVTX icon
Travere Therapeutics
TVTX
+$6.13M
5
MBX
MBX Biosciences
MBX
+$4.95M

Top Sells

1 +$43.9M
2 +$24.3M
3 +$23.8M
4
INSM icon
Insmed
INSM
+$20.2M
5
UNH icon
UnitedHealth
UNH
+$15.8M

Sector Composition

1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS icon
76
Apellis Pharmaceuticals
APLS
$2.57B
$2.08M 0.12%
92,000
+7,700
NGNE icon
77
Neurogene
NGNE
$291M
$1.81M 0.11%
104,339
KRRO icon
78
Korro Bio
KRRO
$84.8M
$1.71M 0.1%
35,719
CNTA
79
Centessa Pharmaceuticals
CNTA
$3.27B
$1.68M 0.1%
+69,240
CATX icon
80
Perspective Therapeutics
CATX
$195M
$1.52M 0.09%
444,383
APLT icon
81
Applied Therapeutics
APLT
$14.4M
$1.26M 0.07%
2,075,991
MRSN
82
DELISTED
Mersana Therapeutics
MRSN
$1.18M 0.07%
152,586
-1
IMVT icon
83
Immunovant
IMVT
$5.51B
$1.18M 0.07%
72,965
-148,535
EYPT icon
84
EyePoint Inc
EYPT
$1.32B
$451K 0.03%
+31,655
CRL icon
85
Charles River Laboratories
CRL
$10.6B
$422K 0.02%
2,700
PCVX icon
86
Vaxcyte
PCVX
$6.35B
$400K 0.02%
11,100
NVAX icon
87
Novavax
NVAX
$1.33B
$390K 0.02%
45,000
-8,900
PRTA icon
88
Prothena Corp
PRTA
$495M
$248K 0.01%
25,398
-467,203
MLTX icon
89
MoonLake Immunotherapeutics
MLTX
$1.23B
$202K 0.01%
+28,200
NUVB.WS icon
90
Nuvation Bio Inc Warrants
NUVB.WS
$19.7M
$27.1K ﹤0.01%
134,028
CGEN icon
91
Compugen
CGEN
$185M
$19.7K ﹤0.01%
13,430
-976,560
ADAP
92
DELISTED
Adaptimmune Therapeutics
ADAP
-2,483,468
BPMC
93
DELISTED
Blueprint Medicines
BPMC
-185,500
OSCR icon
94
Oscar Health
OSCR
$4.81B
-700,000
CGEM icon
95
Cullinan Oncology
CGEM
$642M
-668,233
ETNB
96
DELISTED
89bio
ETNB
-40,000
LUNG icon
97
Pulmonx
LUNG
$82.5M
-651,100
NUVL icon
98
Nuvalent
NUVL
$8.37B
-93,328
SRPT icon
99
Sarepta Therapeutics
SRPT
$2.39B
-68,600
UNH icon
100
UnitedHealth
UNH
$303B
-50,500